Measurement of Gastrointestinal Protein Loss Using Ceruloplasmin Labeled with 67Copper*

AUTOR(ES)

Waldmann, Thomas A.

RESUMO

Ceruloplasmin labeled with 67copper and administered intravenously to dogs, control human subjects, and patients with excessive gastrointestinal loss was shown to fulfill the requirements for a label for quantification of gastrointestinal protein loss. The radiocopper moiety was poorly absorbed from the gastrointestinal tract, not actively secreted into the intestinal tract, and did not alter significantly the metabolism of ceruloplasmin. Approximately 70% of the body pool of ceruloplasmin in both dog and man was within the intravascular space. In control human subjects the mean ceruloplasmin concentration was 30 mg per 100 ml with total circulating and total body ceruloplasmin pools of 15.5 and 22 mg per kg, respectively. In patients with excessive gastrointestinal protein loss secondary to intestinal lymphangiectasia, the serum ceruloplasmin concentration was reduced to 16 mg per 100 ml with a comparable reduction in the total circulating and total body ceruloplasmin pools to 8.8 and 12 mg per kg.

Documentos Relacionados

• THE INCORPORATION OF COPPER INTO CERULOPLASMIN IN VIVO: STUDIES WITH COPPER64 AND COPPER67*
• Direct measurement of the rates of synthesis of plasma proteins in control subjects and patients with gastrointestinal protein loss
• Exchange of Ceruloplasmin Copper with Ionic Cu64 with Reference to Wilson's Disease
• Short-term measurement of catabolic rates using iodine-labeled plasma proteins
• Use of 125I- and 51Cr-Labeled Albumin for the Measurement of Gastrointestinal and Total Albumin Catabolism*